
Bhavyas Pharmaceuticals Private Limited
Manufactures and trades basic chemicals, compounds, and pharmaceuticals since 2019.
Manufactures and trades basic chemicals, compounds, and pharmaceuticals since 2019.
Bhavyas Pharmaceuticals Private Limited (BPPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 April 2019 (Five years and ten months 9 days old ). Its registered office is in Medak, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.20 Cr and a paid-up capital of Rs 2.15 Cr, as per Ministry of Corporate Affairs (MCA) records.
Samba Arigela, Anji Nandipati, and Naresh Ponduri serve as directors at the Company.
Medak, Telangana, India
+91-XXXXXXXXXX
-
U24239TG2019PTC132290
132290
Private Limited Indian Non-Government Company
25 Apr 2019
30 Sep 2023
31 Mar 2023
Unlisted
Roc Hyderabad
Name | Designation | Appointment Date | Status |
---|---|---|---|
Samba Arigela ![]() | Director | 01-Aug-2023 | Current |
Anji Nandipati ![]() | Director | 25-Apr-2019 | Current |
Naresh Ponduri ![]() | Director | Current |
Bhavyas Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 86.29% increase. The company also saw a substantial improvement in profitability, with a 131.01% increase in profit. The company's net worth Soared by an impressive increase of 2335.97%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2023, Bhavyas Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
There are no open charges registered against the company as per our records.
Bhavyas Pharmaceuticals has a workforce of 8 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Bhavyas Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bhavyas Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Bhavyas Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Samba Sivarao Arigela was appointed as a Director was appointed as a Director on 01 Aug 2023 & has been associated with this company since 1 year 7 months .
Bhavyas Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
Anji Reddy Nandipati was appointed as a Director was appointed as a Director on 25 Apr 2019 & has been associated with this company since 5 years 10 months .
Bhavyas Pharmaceuticals Private Limited was registered on 25 Apr 2019 with Roc Hyderabad & aged 5 years 10 months as per MCA records.
Bhavyas Pharmaceuticals Private Limited was incorporated on 25 Apr 2019.
The authorized share capital of Bhavyas Pharmaceuticals Private Limited is ₹ 2.20 Cr and paid-up capital is ₹ 2.15 Cr.
Currently 3 directors are associated with Bhavyas Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Bhavyas Pharmaceuticals Private Limited is Survey No.367 A/1 367 A/3 Peddagotti Mukkala Village Sivampet Man, Dal, Medak, Telangana, India, 502334.
The corporate identification number (CIN) of Bhavyas Pharmaceuticals Private Limited is U24239TG2019PTC132290 and the company number is 132290 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Bhavyas Pharmaceuticals Private Limited has risen by 86.29%.
As Per 2023 financial reports, 8 employees are currently employed by Bhavyas Pharmaceuticals Private Limited.
The financial reports for the fiscal year 2023 indicates that The net worth of Bhavyas Pharmaceuticals Private Limited has experienced an upsurge of 2335.97%.
The most recent Balance Sheet for Bhavyas Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2023.